Bard Acquires Dymax Corporation.MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 5, 1999--C. R. Bard, Inc. (NYSE NYSE See: New York Stock Exchange - BCR BCR B Cell Receptor BCR Business Communications Review (magazine) BCR Banca Comerciala Romana (Romanian bank) BCR Breakpoint Cluster Region BCR Benefit/Cost Ratio BCR Bay City Rollers ) announced today the acquisition of Dymax Corporation, headquartered in Pittsburgh, Pennsylvania. Terms of the purchase were not disclosed. Dymax products include the Site-Rite(R) ultrasound product line, TM18 ultrasound scanners, probes, needle guides and other accessories. The Dymax product line will be sold through Bard's Access Systems subsidiary located in Salt Lake City, Utah For ships of the United States Navy of the same name, see . Salt Lake City is the capital and the most populous city of the U.S. state of Utah. The name of the city is often shortened to Salt Lake, or its initials, S.L.C. . William H. Longfield, chairman and chief executive officer, commented, "Without this real-time visualization technology, needle sticks are done blindly with the use of anatomic landmarks as the only guide. Multiple sticks are time consuming, can cause vessel damage and upset patients." Longfield continued, "The Site Rite product will enable Bard Access Systems to fortify its strong market position in the global vascular access market. Providing ultrasound access guidance to our customers will be a valued addition to our product line." C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc., headquartered in Murray Hill, New Jersey
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion